Value Investing
Value Investing Articles
Here are seven speculative biotech and biohealth stocks where analysts gave huge upside calls during the month of May 2017.
Published:
Last Updated:
Protagonist Therapeutics Inc. (NASDAQ: PTGX) saw its shares move up so much on May 30 that some investors probably just assumed this was a takeover or that the company had major news shaking the...
Published:
Last Updated:
While investors love companies with high dividend yields and those that can be expected to raise dividends in the future, there is a dark side of dividend investing.
Published:
Last Updated:
Here are five of the top picks from Jefferies in which the firm's own analysts expect upside of 25% or more while simultaneously seeing limited downside from the current share price.
Published:
Last Updated:
Merrill Lynch resumed coverage of Noble Energy with a price objective that indicates more than 50% in implied upside for investors.
Published:
Last Updated:
These are the top 10 Sell equivalent ratings seen from analysts during the week of May 15 to May 19, 2017 -- plus a bonus that may as well have been a downgrade to Sell.
Published:
Last Updated:
Exxon Mobil was reiterated as Buy and on the Focus List at Argus, along with a price target of $104. If the firm is proven to be right, Exxon investors would see a total return of about 30% over the...
Published:
Last Updated:
What may have saved the day for Pandora is a board change, an outside investment commitment from KKR and possibly being a buyout target.
Published:
Last Updated:
First Solar was a winner in the days ahead of earnings, and Wednesday has proven to be a big post-earnings win for the leader of U.S. solar power. But are analysts upgrading First Solar for the right...
Published:
Last Updated:
Many value investors have flocked to Gilead Sciences as the world's top biotech stock now that it is valued at a lower multiple than Big Pharma rivals.
Published:
Last Updated:
If you have followed the dust cloud of failed mergers over the years, chances are high that you know the saga of the failed merger between Staples, Inc. (NASDAQ: SPLS) and Office Depot Inc. (NASDAQ:...
Published:
Last Updated:
As of the start of May of 2017, just 21 members of the S&P 500 Index were valued at less than 10 times expected earnings per share.
Published:
Last Updated:
Here are seven very speculative analyst stock picks recently called to rise 100% or exponentially in 2017 or into 2018.
Published:
Last Updated:
Some sell-offs come out of thin air for reasons that most investors had not considered. Maybe it is time for investors to reconsider all of the growth-chasing in favor of some of the safer...
Published:
Last Updated:
Credit Suisse has been negative on Cisco for quite some time, but now the firm's Kulbinder Garcha is becoming a serious bull on the stock.
Published:
Last Updated: